Okava was using the first FDA-approved GLP-1, exenatide, which was authorized for treating human type 2 diabetes in 2005
People with prediabetes can benefit from them, but this use is less common and often off-label
If your insurance doesnt cover it, other discounts may be available to lower the cost
"I have never seen a drug in the history of medicine be on such a rapid path to approval." "Even if youre not overweight, being on these GLP-1 drugs helps to minimize and prevent a repeat recurrent heart attack," Dubrow said
Common side effects include nausea, diarrhea, constipation, stomach discomfort, and reduced appetite
If more than 5 days have passed, skip the missed dose and take the next dose on the next scheduled day according to your dosing schedule